Background: Sex dimorphism strongly impacts tumor biology, with most cancers having a
male predominance. Uniquely, thyroid cancer (TC) is the only nonreproductive cancer with …

Context: TSH is the major growth factor for thyrocytes and may have a causative role in
thyroid cancer. Objective: The objective of the study was to systematically assess the …

Background The prevalence of thyroid carcinoma (TC) and Hashimoto's thyroiditis (HT) has
been increasing dramatically over the past decades. We investigated the relationship …

Abstract Context: Thyroglobulin autoantibodies (TgAb) are primarily measured in serum in
conjunction with thyroglobulin (Tg)—the primary tumor marker used to monitor patients with …

Context: TSH is the main factor involved in the control of proliferation of thyrocytes. Recently,
a strong relationship between serum TSH and risk of thyroid malignancy has been reported …

Thyroglobulin autoantibodies (TgAb) are detected at diagnosis or during treatment in
approximately 25% of patients with differentiated thyroid cancer (DTC). When present, TgAb …

Background: Even though the presence of antithyroglobulin antibodies (TgAbs) represents a
significant problem in the follow-up of patients with differentiated thyroid cancer (DTC), the …

The possible association between Hashimoto's thyroiditis (HT) and papillary thyroid
carcinoma (PTC) is a still debated issue. We analyzed the frequency of PTC, TSH levels and …

Objective It remains inconclusive whether Hashimoto's thyroiditis (HT) predisposes patients
to the development of papillary thyroid carcinoma (PTC). We conducted a meta-analysis of …

Background: Serum thyrotropin (TSH) concentration and thyroid autoimmunity may be of
prognostic importance in differentiated thyroid cancer (DTC). Preoperative serum TSH level …